• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Orthopedic Devices

Nobel Biocare Holding AG

+ Add to Watchlist


13.850 CHF 0.200 1.42%

As of 11:43:42 ET on 07/28/2014.

Snapshot for Nobel Biocare Holding AG (NOBN)

Open: 14.100 Day's Range: 13.750 - 14.100 Volume: 178,910
Previous Close: 14.050 52wk Range: 10.974 - 15.305 1-Yr Rtn: +23.40%

Stock Chart for NOBN

No chart data available.
  • NOBN:SW 13.850
  • 1D
  • 1M
  • 1Y
Interactive NOBN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NOBN

Current P/E Ratio (ttm) 33.5286
Estimated P/E(12/2014) 27.8786
Relative P/E vs. SMI 1.6831
Earnings Per Share (EUR) (ttm) 0.3400
Est. EPS (EUR) (12/2014) 0.4090
Est. PEG Ratio 1.5432
Market Cap (M CHF) 1,714.42
Shares Outstanding (M) 123.78
30 Day Average Volume 312,219
Price/Book (mrq) 4.2946
Price/Sale (ttm) 2.4814
Dividend Indicated Gross Yield 1.44%
Cash Dividend (CHF) 0.2000
Dividend Ex-Date 03/28/2014
5 Year Dividend Growth -18.32%
Next Earnings Announcement 08/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NOBN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for NOBN

Nobel Biocare Holding AG develops and produces dental implants and dental prosthetics. The Company manufactures permanent replacements for tooth roots, and dental crowns and bridges. Nobel Biocare sells under the brand names Branemark System, Steri-Oss/Replace, and Procera on the global market.

Richard T LaubeChief Executive OfficerOliver WalkerChief Financial Officer
Hans GeiselhoringerExec VP:Global ResearchMelker NilssonExec VP:Global Customer
More Company Profile & Key Executives for NOBN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil